1st Quarter - Report · 2026

Filing UUID: 6701d1aa-2ac3-4af4-811c-529c3df5833c
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-17 14:41:42
Income (reported): $60,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

LMH STRATEGIC SOLUTIONS

Contact: ALANNA TEMME
Phone: +1 202-503-5189
Address: zip:20007, city:Washington, state:DC, street:2231 48th Street NW

Client

STEALTH BIOTHERAPEUTICS INC.

Biotechnology company.

State: MA
Country: US
Effective date: 2025-03-01

Issues lobbied + lobbyists

`HCR` — Health Issues

Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs.

Lobbyists: ALANNA TEMME (covered position: Legislative Director, U.S. Representative Jon Porter); SONIA GOH; SOPHIE KHANAHMADI (covered position: Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions); MAXIMILIAN WALTER

Government entities lobbied: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

`PHA` — Pharmacy

Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs. Drug pricing reform. Food and Drug Administration legislative and regulatory issues.

Lobbyists: ALANNA TEMME; SONIA GOH; SOPHIE KHANAHMADI; MAXIMILIAN WALTER